(Q42731927)

6 November 2017

title

Estimating the risk of drug-induced proarrhythmia using human induced pluripotent stem cell-derived cardiomyocytes (English)

1 reference

Human Induced Pluripotent Stem Cells

6 November 2017

main subject

1 reference

1 reference

Liang Guo

1

1 reference

6 November 2017

Rory M C Abrams

2

1 reference

6 November 2017

Joshua E Babiarz

3

1 reference

6 November 2017

Jennifer D Cohen

4

1 reference

6 November 2017

Sei Kameoka

5

1 reference

6 November 2017

Martin J Sanders

6

1 reference

6 November 2017

Eric Chiao

7

1 reference

6 November 2017

Kyle L Kolaja

8

1 reference

6 November 2017

publication date

20 June 2011

1 reference

6 November 2017

published in

Toxicological Sciences

1 reference

6 November 2017

volume

123

1 reference

6 November 2017

issue

1

1 reference

6 November 2017

page(s)

281-289

1 reference

describes a project that uses

6 November 2017

induced pluripotent stem cell

1 reference

based on heuristic

inferred from title

cites work

Physiology and pharmacology of the cardiac pacemaker ("funny") current

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFR158

Prediction of drug-induced cardiotoxicity using human embryonic stem cell-derived cardiomyocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFR158

Transcriptional and functional profiling of human embryonic stem cell-derived cardiomyocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFR158

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFR158

Calcium and cardiac arrhythmias: DADs, EADs, and alternans

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFR158

Effects of antipsychotic drugs on I(to), I (Na), I (sus), I (K1), and hERG: QT prolongation, structure activity relationship, and network analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFR158

Translational prospects for human induced pluripotent stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFR158

Use and application of stem cells in toxicology

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFR158

Safety of non-antiarrhythmic drugs that prolong the QT interval or induce torsade de pointes: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFR158

Cardiotoxicity of digitalis glycosides: roles of autonomic pathways, autacoids and ion channels

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFR158

Clinical assessment of drug-induced QT prolongation in association with heart rate changes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFR158

Rates of torsades de pointes associated with ciprofloxacin, ofloxacin, levofloxacin, gatifloxacin, and moxifloxacin

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFR158

A morphological biosensor for mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFR158

QT interval prolongation: preclinical and clinical testing arrhythmogenesis in drugs and regulatory implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFR158

Determination of electrical properties of ES cell-derived cardiomyocytes using MEAs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFR158

Quantified proarrhythmic potential of selected human embryonic stem cell-derived cardiomyocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFR158

Tetrodotoxin-sensitive inactivation-resistant sodium channels in pacemaker cells influence heart rate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFR158

Stem cells and their derivatives: a renaissance in cardiovascular translational research

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFR158

A rabbit Langendorff heart proarrhythmia model: predictive value for clinical identification of Torsades de Pointes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFR158

Nonclinical proarrhythmia models: predicting Torsades de Pointes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFR158

In vitro models of proarrhythmia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFR158

The utility of hERG and repolarization assays in evaluating delayed cardiac repolarization: influence of multi-channel block

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFR158

Lack of action potential-prolonging effect of terfenadine on rabbit myocardial tissue preparations

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFR158

QT-screen: high-throughput cardiac safety pharmacology by extracellular electrophysiology on primary cardiac myocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFR158

Concordance of the toxicity of pharmaceuticals in humans and in animals

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFR158

The action potential and comparative pharmacology of stem cell-derived human cardiomyocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFR158

Antimicrobials and the risk of torsades de pointes: the contribution from data mining of the US FDA Adverse Event Reporting System

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFR158

Relationships between preclinical cardiac electrophysiology, clinical QT interval prolongation and torsade de pointes for a broad range of drugs: evidence for a provisional safety margin in drug development

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFR158

Spiropiperidine CCR5 antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFR158

HERG, a primary human ventricular target of the nonsedating antihistamine terfenadine

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFR158

Key clinical considerations for demonstrating the utility of preclinical models to predict clinical drug-induced torsades de pointes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFR158

Antiarrhythmic and proarrhythmic properties of QT-prolonging antianginal drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFR158

Induction of pluripotent stem cells from adult human fibroblasts by defined factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFR158

The application of cell-based label-free technology in drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFR158

Global expression profile of highly enriched cardiomyocytes derived from human embryonic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFR158

21 January 2018

Identifiers

DOI

10.1093/TOXSCI/KFR158

1 reference

release_rgm5nnlzvrewhbh3wtdail5sfe

6 November 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/rgm5nnlzvrewhbh3wtdail5sfe

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference